Bio-Rad Laboratories Financial Overview
Bio-Rad Laboratories's market cap is currently $8.14B. The company's EPS TTM is $2.26; its P/E ratio is -12.54; Bio-Rad Laboratories is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $2.71. See an overview of income statement, balance sheet, and cash flow financials.
